Science Resources RSS Feeds
|
 |
 |
 |
Hodgkin Lymphoma Current Events | Hodgkin Lymphoma News
|
| Page
1 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516)
Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when... view more... (2003-08-13)
Model predicts risk of breast cancer for young women treated for Hodgkin lymphoma
Young women who are treated for Hodgkin lymphoma with chest radiation therapy have a high cumulative absolute risk of developing breast cancer later in life. view more (2005-10-05)
USC researchers find new clues to risk of Hodgkin lymphoma
A long-term study of twins has led University of Southern California (USC) researchers to find potential links between Hodgkin lymphoma and levels of an immune response protein (interleukin-12). view more (2008-04-02)
Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. view more (2008-01-03)
Hepatitis C increases risk of non-Hodgkin lymphoma
Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma (malignancy involving lymphatic tissue) of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma, according to a study in the May 9 issue of JAMA. view more (2007-05-09)
Study analyzes heart attack mortality risk associated with Hodgkin disease treatments
Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks. view more (2007-02-07)
Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern. view more (2008-10-09)
Promising treatment target found in Hodgkin lymphoma
Dana-Farber Cancer Institute scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. view more (2007-07-31)
Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Quantitative PET Imaging Finds Early Determination of Effectiveness of Cancer Treatment
With positron emission tomography (PET) imaging, seeing is believing: Evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma (NHL) typically involves visual interpretation of scans of cancer tumors. view more (2007-10-24)
New therapy prevents dangerous side effect for lymphoma patients
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
FLT PET Assesses Treatment Response on Tumor Growth—Not Size—With Non-Hodgkin's Lymphoma
Positron emission tomography (PET)—with the radiolabeled thymidine analog [18F]Fluorothymidine (FLT)—is "a promising, sensitive tool" for assessing drug effects on tumor growth in patients with diffuse large B-cell lymphoma. view more (2006-06-07)
Hodgkin disease survivors face higher risk for stroke later in life
Patients surviving childhood Hodgkin disease suffer strokes later in life at rates about four times that of the general population, UT Southwestern Medical Center researchers have found. view more (2005-10-14)
DNA differences may influence risk of Hodgkin disease
A new analysis has found that certain variations in genes that repair DNA can affect a person's risk of developing Hodgkin disease. view more (2009-03-09)
PET-CT detects muscular lymphoma better than CT
PET-CT is better for early detection of muscular lymphoma than CT alone, according to a new study conducted by radiologists at the University of Minnesota in Minneapolis. view more (2007-05-07)
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma. view more (2008-05-16)
Attention: Extra-hepatic manifestation of hepatitis C virus infection
In 1994, the team of Tchernev and Petrova from Alexandrovska Hospital in Sofia examined a female patient with liver cirrhosis caused by chronic Hepatitis C virus (HCV). view more (2008-01-17)
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease. view more (2009-06-25)
Work of Nobel-prize winning scientist Dorothy Hodgkin to be Celebrated with a Landmark Event at Oxford University
The work of the Nobel-prize winning crystallographer, Dorothy Hodgkin (1910-1994), which led to the synthesis of penicillin, vitamin B12 and insulin will be honoured by the Royal Society of Chemistry (RSC) at the University of Oxford on Monday 14 May 2001 through the designation of a National Historical Chemical Landmark. Dorothy Crowfoot Hodgkin... view more... (2001-05-10)
News from Cancer: Risk factors for deadly form of lymphoma
A new study indicates that the incidence of mantle cell lymphoma, an aggressive type of non-Hodgkin's lymphoma, is on the rise, most frequently striking men, Caucasians and older individuals. view more (2008-07-07)
|
|
| Page
1 of
8 |
149 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
